clopidogrel and Hypertension

clopidogrel has been researched along with Hypertension in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (33.80)	29.6817
2010's	38 (53.52)	24.3611
2020's	9 (12.68)	2.80

Authors

Authors	Studies
Fang, W; Guo, X; Jiang, H; Jin, X; Liu, Y; Sun, P; Yu, J	1
Fan, H; Li, J; Li, X; Li, Y; Liu, T; Ma, L; Niu, X; Ren, J; Wang, Y; Wu, X; Zhang, K	1
Bath, PM; Chen, G; Huang, P; Jiang, Y; Jing, J; Johnston, SC; Li, H; Li, Z; Lin, J; Liu, L; Meng, X; Tian, X; Wang, A; Wang, F; Wang, Y; Xie, X; Zhao, X; Zuo, Y	1
Kozieł-Siołkowska, M; Lip, GY; Shantsila, E	1
Boyd, K; Brown, SA; Thomason, AR	1
Huang, J; Liao, F; Shu, X; Tang, J	1
Akbari, A; Barry, JP; Gravenor, MB; Halcox, JP; Harris, DE; Jenkins, GH; Lacey, A; Obaid, DR; Smith, DA	1
An, X; Liu, Y; Liu, YJ; Lv, H; Niu, XH; Tan, R; Xia, YL; Yang, X; Yin, X	1
Abe, K; Ikeda, Y; Kitagawa, K; Kitazono, T; Matsumoto, M; Minematsu, K; Nagao, T; Nagata, I; Nanto, S; Nishikawa, M; Ogawa, A; Shirai, T; Tanahashi, N; Toyoda, K; Uchiyama, S; Yamagami, H	1
Hatakeyama, Y; Horino, T; Matsumoto, T; Okuhara, Y; Terada, Y	1
Chen, X; Cui, H; Du, W; Ji, L; Li, X; Liu, T; Su, J; Tong, M; Xia, Y; Xu, H; Yang, J; Yao, Q; Yu, J; Yu, Q; Zhang, J; Zheng, Y; Zhu, H; Zhu, Y	1
He, X; Hou, J; Li, B; Li, C; Liu, Z; Wu, H; Yang, M; Zhang, Q; Zhao, P; Zhong, M; Zhong, W; Zhong, Z	1
Baumgartner, I; Berger, JS; Björck, M; Blomster, JI; Fowkes, FGR; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Norgren, L; Patel, MR; Rockhold, FW; Wojdyla, DM	1
Huang, J; Liu, L; Tang, X; Zhang, X	1
Benzuly, KH; Unger, ED; Youmans, QR	1
Dong, N; Liang, L; Liu, ZZ; Lu, BC; Shi, XJ	1
Akturk, IF; Caglar, FN; Caglar, IM; Erturk, M; Surgit, O; Tuncer, N; Uzun, F; Yalcın, AA	1
Bell, PR; Bown, MJ; Dennis, MJ; London, NJ; McCarthy, MJ; Nasim, A; Naylor, AR; Sayers, RD	1
Cui, W; Du, J; Jia, LX; Li, TT; Liu, O; Qi, GM; Qi, YF; Yang, M; Zhang, WM	1
Du, XJ; Kiriazis, H	1
Li, G; Li, ZQ; Yang, JD; Yang, QY	1
De Miguel, C; Inscho, EW; Osmond, DA; Pollock, JS; Yamamoto, T; Zhang, S	1
Giachini, FR; Inscho, EW; Leite, R; Lima, VV; Osmond, DA; Tostes, RC; Webb, RC	1
Daels, FP; de la Rosette, JJ; Erkan, E; Gaizauskas, A; Melekos, M; Ozgok, Y; Rioja, J; Varshney, AK	1
Bischof, F; Ernemann, U; Silber, T; Ziemann, U	1
Ahmed, O; Daniel, E; Grunwald, JE; Maguire, MG; Martin, DF; Ying, GS	1
Benavente, OR; Field, TS; Hart, RG; McClure, LA; Odden, MC; Peralta, CA; Pergola, PE; Sawaya, BP; White, CL	1
Cai, YF; Chen, XM; Chen, YB; Huang, M; Jin, J; Li, JL; Liu, R; Yu, WB; Zhao, M; Zhao, YQ; Zhou, ZY	1
Buck, J; Cram, P; Gage, BF; Kaboli, P; Vaughan Sarrazin, MS	1
Gao, F; Jiang, WJ	1
Bilkova, D; Kala, P; Marinov, I; Motovska, Z; Petr, R; Simek, S; Widimsky, P	1
Korenstein, D; McGinn, T; Stulman, J	1
Molony, NC; Rainsbury, JW	1
Chung, HS; Kim, JH; Kwon, TH; Moon, HJ; Park, YK	1
Hashimoto, A; Ito, H; Matsumoto, Y; Miyakoda, G; Yao, H	1
Carneiro, FS; Giachini, FR; Inscho, EW; Lima, VV; Osmond, DA; Tostes, RC; Webb, RC; Zhang, S	1
Zeng, C	1
Demiropoulos, FP; Gerassimidis, TS; Karamanos, DG; Karkos, CD; Papadimitriou, DN; Papazoglou, KO	1
Douma, S; Ferro, A; Gkaliagkousi, E; Passacquale, G; Zamboulis, C	1
Cimino, E; Conca, P; Coppola, A; De Simone, C; Di Capua, M; Di Minno, G; Guida, A; Morisco, C; Tufano, A	1
Bazan, C; Benavente, MF; Benavente, OR; Coffey, C; Conwit, R; Hart, RG; Heberling, PA; Howard, G; McClure, LA; Pearce, L; Pergola, P; Roldan, A; Szychowski, JM; Talbert, R; Vidal-Pergola, G; White, CL	1
Kamal, AK; Khan, M	1
Ballotta, E; Baracchini, C; Gruppo, M; Lorenzetti, R; Mazzalai, F; Meneghetti, G	1
Al Suwaidi, J; Alsheikh-Ali, AA; Anderson, FA; Awad, HH; Goldberg, RJ; Gore, JM; Zubaid, M	1
D'Urbano, M; De Servi, S; Navarese, EP; Savonitto, S	1
Dwivedi, G; Felmeden, DC; Lip, GY	1
Ahmed, N; Egido, JA; Ford, GA; Lees, KR; Mazya, M; Mikulik, R; Toni, D; Wahlgren, N	1
Arauz, A; Benavente, MF; Benavente, OR; Coffey, CS; Conwit, R; Del Brutto, OH; Demaerschalk, BM; Hart, RG; Irby, LH; Kase, CS; McClure, LA; Meissner, I; Meyer, BC; Pearce, LA; Pergola, PE; Peri, K; Pretell, EJ; Roldan, A; Szychowski, JM; White, CL	1
Alexander, JH; Alexander, KP; Broderick, S; Granger, CB; Hess, CN; Lopes, RD; Mahaffey, KW; Newby, LK; Peterson, ED; Piccini, JP; Shaw, LK	1
Bao, Y; Hua, Y; Jiang, L; Jiao, L; Li, S; Li, Y; Ling, F; Liu, X; Miao, Z; Wu, H; Wu, J; Zhu, F; Zhu, J	1
Abrams, J; Berra, K; Blankenship, JC; Dallas, AP; Douglas, PS; Fihn, SD; Foody, JM; Gardin, JM; Gerber, TC; Hinderliter, AL; King, SB; Kligfield, PD; Krumholz, HM; Kwong, RY; Lim, MJ; Linderbaum, JA; Mack, MJ; Munger, MA; Prager, RL; Sabik, JF; Shaw, LJ; Sikkema, JD; Smith, CR; Smith, SC; Spertus, JA; Williams, SV	1
MacWalter, RS; Shirley, CP	1
Andrié, R; Bauriedel, G; Jabs, A; Lüderitz, B; Schneider, M; Skowasch, D	1
Ornato, JP	1
Baumgartner, RW; Bogousslavsky, J; Georgiadis, D; Michel, P	1
Felmeden, DC; Lip, GY	1
Malcolm, J; Meggison, H; Sigal, R	1
Cay, S; Korkmaz, S; Yilmaz, MB	1
Hacke, W	1
Arzur, J; Bessodes, A; Coquerel, A; De la Gastine, B	1
Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A	1
Heliopoulos, I; Maltezos, E; Papanas, N; Piperidou, H	1
Bugra, Z; Ekmekci, A; Meric, M; Ozben, B; Umman, S	1
Arnaout, A; Malcolm, J; Sigal, R	1
Das, K; Karabatsou, K; Rainov, NG; Sinha, A	1
Graciano, ML; Jackson, K; Kobori, H; Navar, LG; Nishiyama, A; Ortiz, RM; Prieto-Carrasquero, MC; Seth, DM	1
Chen, X; Chen, Y; Li, J; Shi, S; Tu, X; Wang, J; Xie, Y	1
Kim, S; Lipsitz, EC	1
Bhargava, B; Kent, KM; Kim, HS; Kollum, M; Kolodgie, FD; Mintz, GS; Virmani, R; Waksman, R	1
Fonarow, GC; Horwich, TB	1

Reviews

12 review(s) available for clopidogrel and Hypertension

Article	Year
Antiplatelet agents and anticoagulants for hypertension. The Cochrane database of systematic reviews, 2022, 07-28, Volume: 7 Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin	2022
Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis. PloS one, 2018, Volume: 13, Issue:6 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Stroke; Thrombosis; Warfarin	2018
Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2013, Volume: 46, Issue:2 Topics: Angioscopy; Aspirin; Carotid Artery Diseases; Clinical Protocols; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Humans; Hypertension; Intracranial Embolism; Intracranial Hemorrhages; Intraoperative Care; Medical Audit; Platelet Aggregation Inhibitors; Postoperative Care; Practice Guidelines as Topic; Predictive Value of Tests; Quality of Health Care; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial	2013
Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor. Current medical research and opinion, 2011, Volume: 27, Issue:11 Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Angiography; Diabetes Mellitus; Female; Humans; Hypertension; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2011
Antiplatelet agents and anticoagulants for hypertension. The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin	2011
A benefit-risk assessment of agents used in the secondary prevention of stroke. Drug safety, 2002, Volume: 25, Issue:13 Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Aspirin; Clinical Trials as Topic; Clopidogrel; Coumarins; Dipyridamole; Humans; Hypertension; Hypoglycemic Agents; Insulin; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Smoking Cessation; Stroke; Ticlopidine; Warfarin	2002
[Treatment of acute stroke -- an overview]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:9 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Brain Edema; Case-Control Studies; Cerebral Infarction; Clinical Trials, Phase IV as Topic; Clopidogrel; Contraindications; Double-Blind Method; Fibrinolytic Agents; Heparin; Humans; Hypertension; Immunoglobulin Fab Fragments; Intracranial Pressure; Intubation, Intratracheal; Ischemic Attack, Transient; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Placebos; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Respiration, Artificial; Stroke; Thrombolytic Therapy; Ticlopidine; Time Factors; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Ultrasonography	2003
Antiplatelet agents and anticoagulants for hypertension. The Cochrane database of systematic reviews, 2004, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin	2004
Prevention of cardiovascular events in diabetes. Clinical evidence, 2003, Issue:10 Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Bypass; Diabetic Angiopathies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking Cessation; Ticlopidine	2003
Multiple coronary thrombosis and stent implantation to the subtotally occluded right renal artery in a patient with essential thrombocytosis: a case report with review. Journal of thrombosis and thrombolysis, 2006, Volume: 22, Issue:1 Topics: Angina, Unstable; Angioplasty; Clopidogrel; Coronary Thrombosis; Female; Humans; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Renal Artery Obstruction; Thrombocythemia, Essential; Thrombosis; Ticlopidine	2006
Prevention of cardiovascular events in diabetes. Clinical evidence, 2006, Issue:15 Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Clopidogrel; Diabetic Angiopathies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking Cessation; Ticlopidine	2006
Prevention of heart failure. Current cardiology reports, 2002, Volume: 4, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Disease Progression; Health Behavior; Heart Failure; Humans; Hyperlipidemias; Hypertension; Platelet Aggregation Inhibitors; Prevalence; Renal Insufficiency; Risk Factors; Smoking; Ticlopidine; Ventricular Dysfunction, Left	2002

Trials

10 trial(s) available for clopidogrel and Hypertension

Article	Year
Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack. Stroke, 2022, Volume: 53, Issue:9 Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Hypertension; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Treatment Outcome	2022
Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I. Stroke, 2021, Volume: 52, Issue:4 Topics: Aged; Blood Pressure; Clopidogrel; Double-Blind Method; Female; Humans; Hypertension; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Secondary Prevention; Thromboembolism	2021
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2018, Volume: 55, Issue:1 Topics: Adenosine; Aged; Clopidogrel; Female; Hospitalization; Humans; Hypertension; Incidence; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome; Vascular Surgical Procedures	2018
Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology, 2016, Volume: 123, Issue:2 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Bevacizumab; Cardiovascular Diseases; Clopidogrel; Female; Fluorescein Angiography; Humans; Hypertension; Intravitreal Injections; Male; Odds Ratio; Platelet Aggregation Inhibitors; Ranibizumab; Retinal Hemorrhage; Risk Factors; Ticlopidine; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Warfarin; Wet Macular Degeneration	2016
Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:1 Topics: Aspirin; Blood Pressure; Blood Pressure Determination; Clopidogrel; Drug Therapy, Combination; Female; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Severity of Illness Index; Stroke, Lacunar; Ticlopidine; Treatment Outcome	2016
Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox". Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:5 Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Aspirin; Body Mass Index; Cell Adhesion Molecules; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Microfilament Proteins; Phosphoproteins; Platelet Aggregation Inhibitors; Renal Insufficiency; Sex Factors; Smoking; Ticlopidine; Treatment Outcome	2009
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:2 Topics: Antihypertensive Agents; Aspirin; Clopidogrel; Cognition Disorders; Humans; Hypertension; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Research Design; Secondary Prevention; Stroke; Ticlopidine	2011
Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke, 2012, Volume: 43, Issue:6 Topics: Age Factors; Aged; Aspirin; Body Weight; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Hypertension; Injections, Intravenous; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Registries; Risk Factors; Stroke; Ticlopidine; Tissue Plasminogen Activator	2012
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:6 Topics: Aged; Antihypertensive Agents; Aspirin; Black or African American; Blood Pressure; Chi-Square Distribution; Clopidogrel; Diabetes Mellitus; Drug Administration Schedule; Drug Therapy, Combination; Ethnicity; Female; Hispanic or Latino; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; North America; Platelet Aggregation Inhibitors; Prevalence; Racial Groups; Risk Factors; Secondary Prevention; Smoking; South America; Spain; Stroke; Ticlopidine; Time Factors; Treatment Outcome; White People	2013
Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a Chinese population. Stroke, 2012, Volume: 43, Issue:12 Topics: Adult; Aged; Angioplasty; Asian People; Aspirin; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipidemias; Hypertension; Infarction, Middle Cerebral Artery; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Secondary Prevention; Stents; Ticlopidine; Treatment Outcome	2012

Other Studies

49 other study(ies) available for clopidogrel and Hypertension

Article	Year
The Clinical Efficacy of Clopidogrel Bisulfate Tablets Combined with Olmesartan Medoxomil for Ischemic Stroke with Hypertension and the Effect of Angiotensin II Type 1 Receptor Level on Prognosis. Computational and mathematical methods in medicine, 2021, Volume: 2021 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Clopidogrel; Computational Biology; Drug Therapy, Combination; Female; Humans; Hypertension; Ischemic Stroke; Male; Middle Aged; Olmesartan Medoxomil; Platelet Aggregation Inhibitors; Prognosis; Receptor, Angiotensin, Type 1; Treatment Outcome	2021
Evaluation of the association between admission systolic blood pressure and the choice of initial antiplatelet therapy for minor ischemic stroke in real-world. Journal of clinical hypertension (Greenwich, Conn.), 2022, Volume: 24, Issue:4 Topics: Aged; Aspirin; Blood Pressure; Clopidogrel; Drug Therapy, Combination; Humans; Hypertension; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Treatment Outcome	2022
Geriatric Pharmacotherapy Case Series: Potential Drug Interactions With Antiplatelet Medications and Cannabidiol-A Focus on P2Y12 Inhibitors. The Senior care pharmacist, 2023, Apr-01, Volume: 38, Issue:4 Topics: Activities of Daily Living; Aged; Cannabidiol; Clopidogrel; Humans; Hypertension; Male; Myocardial Infarction; Pain; Platelet Aggregation Inhibitors; Stroke	2023
Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy. Clinical neurology and neurosurgery, 2023, Volume: 231 Topics: Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Hypertension; Peptic Ulcer; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine	2023
Early Discontinuation of P2Y Journal of the American Heart Association, 2019, 11-05, Volume: 8, Issue:21 Topics: Age Factors; Aged; Aged, 80 and over; Clopidogrel; Cohort Studies; Drug Prescriptions; Female; Hemorrhage; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Retreatment; Retrospective Studies; Stroke; Thromboembolism; Wales	2019
Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts. Hypertension (Dallas, Tex. : 1979), 2020, Volume: 76, Issue:6 Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Blood Platelets; Clopidogrel; Fibroblasts; Humans; Hypertension; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Platelet Activation; Platelet Aggregation Inhibitors; Transforming Growth Factor beta1	2020
Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury. Clinical and experimental nephrology, 2021, Volume: 25, Issue:10 Topics: Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Diabetes Mellitus; Female; Gastroesophageal Reflux; Glomerular Filtration Rate; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Kidney; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Steroids; Time Factors	2021
The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population. PloS one, 2017, Volume: 12, Issue:3 Topics: Aged; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; DNA Methylation; Drug Resistance; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Middle Aged; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Serum Albumin; Sex Characteristics; Ticlopidine; Vascular System Injuries	2017
Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China. European journal of clinical pharmacology, 2018, Volume: 74, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Aged; Asian People; Chi-Square Distribution; China; Clinical Decision-Making; Clopidogrel; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Hemorrhage; Heterozygote; Homozygote; Humans; Hypertension; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Precision Medicine; Retrospective Studies; Risk Factors; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome	2018
A Young Woman With Chest Pain. JAMA, 2018, Dec-18, Volume: 320, Issue:23 Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aortic Dissection; Aspirin; Chest Pain; Clopidogrel; Coronary Angiography; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Metoprolol; Platelet Aggregation Inhibitors; Stroke Volume; Troponin I	2018
Platelet Surface CD62p and Serum Vitamin D Levels are Associated with Clopidogrel Resistance in Chinese Patients with Ischemic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:5 Topics: Aged; Asian People; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; China; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Stroke; Treatment Outcome; Vitamin D; Vitamin D Deficiency	2019
Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2014, Volume: 20, Issue:7 Topics: Adult; Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Resistance; Female; Humans; Hypertension; Male; Mean Platelet Volume; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Stents; Ticlopidine	2014
Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:6 Topics: Angiotensin II; Animals; Clopidogrel; Fibrosis; Hypertension; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocarditis; Myocardium; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine; Transforming Growth Factor beta	2013
Pro-inflammatory role of platelets in hypertension-mediated end-organ damage : Editorial to: "Inhibition of Platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis" by L.-X. Jia et al. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:6 Topics: Animals; Clopidogrel; Fibrosis; Hypertension; Male; Myocarditis; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine	2013
Acquired pure red cell aplasia due to treatment with clopidogrel: first case report. Journal of thrombosis and thrombolysis, 2014, Volume: 38, Issue:2 Topics: Clopidogrel; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Red-Cell Aplasia, Pure; Ticlopidine	2014
Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension. American journal of physiology. Renal physiology, 2014, Mar-15, Volume: 306, Issue:6 Topics: Angiotensin II; Animals; Clopidogrel; Hypertension; Kidney; Male; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2Y12; Renal Circulation; Thromboxane B2; Ticlopidine	2014
DTB Select: 3 \| March 2014. Drug and therapeutics bulletin, 2014, Volume: 52, Issue:3 Topics: Alzheimer Disease; Antibodies, Monoclonal, Murine-Derived; Automobile Driving; Child; Chronic Pain; Clopidogrel; Hepatitis B; Histamine H2 Antagonists; Humans; Hypertension; Practice Guidelines as Topic; Practice Patterns, Physicians'; Proton Pump Inhibitors; Respiratory Tract Infections; Rituximab; Thiophenes; Ticlopidine	2014
Anti-platelet therapy with clopidogrel prevents endothelial dysfunction and vascular remodeling in aortas from hypertensive rats. PloS one, 2014, Volume: 9, Issue:3 Topics: Adenosine Diphosphate; Animals; Aorta; Blood Pressure; Clopidogrel; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Hypertension; Male; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Receptors, Purinergic P2Y; Thionucleotides; Ticlopidine; Vascular Remodeling; Vasoconstriction; Vasodilation	2014
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World journal of urology, 2015, Volume: 33, Issue:6 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Comorbidity; Coumarins; Diabetes Mellitus; Female; Humans; Hypertension; Kidney Calculi; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Prevalence; Prospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urolithiasis; Young Adult	2015
Analysis of periinterventional complications of intracranial angioplasty and stenting: a single center experience. European journal of radiology, 2014, Volume: 83, Issue:12 Topics: Aged; Angioplasty; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Diabetes Complications; Female; Humans; Hyperlipidemias; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Reperfusion Injury; Retrospective Studies; Stents; Stroke; Ticlopidine	2014
Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke. Acta pharmacologica Sinica, 2016, Volume: 37, Issue:7 Topics: Aged; Asian People; Case-Control Studies; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Resistance; Female; Genetic Association Studies; Genotype; Humans; Hypertension; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Pregnane X Receptor; Protective Factors; Receptors, Purinergic P2Y12; Receptors, Steroid; Risk Factors; Stroke; Ticlopidine	2016
Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System. American heart journal, 2016, Volume: 179 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diabetes Mellitus; Female; Guideline Adherence; Heart Failure; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Risk Assessment; Stroke; Ticlopidine; United States; United States Department of Veterans Affairs; Warfarin	2016
Transient ischemic attack associated with stenosis of accessory middle cerebral artery: a case report. Clinical neurology and neurosurgery, 2009, Volume: 111, Issue:7 Topics: Aphasia; Aspirin; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; Humans; Hypertension; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Magnetic Resonance Angiography; Male; Middle Aged; Middle Cerebral Artery; Paresis; Platelet Aggregation Inhibitors; Ticlopidine	2009
Clopidogrel for preventing cardiovascular events. The Mount Sinai journal of medicine, New York, 2009, Volume: 76, Issue:2 Topics: Aspirin; Clopidogrel; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Hypertension; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Stroke; Ticlopidine	2009
Clopidogrel versus low-dose aspirin as risk factors for epistaxis. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2009, Volume: 34, Issue:3 Topics: Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Epistaxis; Humans; Hypertension; Myocardial Ischemia; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2009
Spontaneous spinal epidural hematoma: an urgent complication of adding clopidogrel to aspirin therapy. Journal of the neurological sciences, 2009, Oct-15, Volume: 285, Issue:1-2 Topics: Aspirin; Clopidogrel; Coronary Stenosis; Decompression, Surgical; Drug Interactions; Hematoma, Epidural, Spinal; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Spinal Cord; Stents; Ticlopidine; Treatment Outcome	2009
Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010, Volume: 30, Issue:2 Topics: Animals; Aspirin; Brain Ischemia; Cells, Cultured; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Endothelial Cells; Epoprostenol; Humans; Hypertension; Laser-Doppler Flowmetry; Male; Nitric Oxide; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Tetrazoles; Ticlopidine	2010
Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats. Clinical science (London, England : 1979), 2010, Volume: 118, Issue:7 Topics: Acetylcholine; Adenosine Diphosphate; Angiotensin II; Animals; Blotting, Western; Clopidogrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Purinergic P2Y Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thionucleotides; Ticlopidine; Vasodilation; Vasodilator Agents	2010
Clopidogrel application: beyond coronary artery disease. Clinical science (London, England : 1979), 2010, Volume: 118, Issue:7 Topics: Animals; Clopidogrel; Hypertension; Male; Mesenteric Arteries; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine	2010
Thirty-day outcome following carotid artery stenting: a 10-year experience from a single center. Cardiovascular and interventional radiology, 2010, Volume: 33, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiography; Carotid Stenosis; Clopidogrel; Comorbidity; Endarterectomy, Carotid; Female; Humans; Hyperlipidemias; Hypertension; Logistic Models; Male; Middle Aged; Premedication; Prognosis; Retrospective Studies; Risk Factors; Stents; Stroke; Survival Analysis; Ticlopidine; Treatment Outcome	2010
Platelet activation in essential hypertension: implications for antiplatelet treatment. American journal of hypertension, 2010, Volume: 23, Issue:3 Topics: Antihypertensive Agents; Blood Platelet Disorders; Blood Platelets; Clopidogrel; Humans; Hypertension; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	2010
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. Thrombosis and haemostasis, 2010, Volume: 103, Issue:6 Topics: Acute Coronary Syndrome; Anticoagulants; Clopidogrel; Coagulants; Comorbidity; Coronary Angiography; Dyspnea; Factor VIII; Fatal Outcome; Hemophilia A; Heparin, Low-Molecular-Weight; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Practice Guidelines as Topic; Renal Insufficiency; Ticlopidine	2010
Atrial fibrillation, is warfarin the only option for stroke prevention? JPMA. The Journal of the Pakistan Medical Association, 2011, Volume: 61, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clopidogrel; Evidence-Based Medicine; Follow-Up Studies; Humans; Hypertension; Irbesartan; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin	2011
Predictors of neck bleeding after eversion carotid endarterectomy. Journal of vascular surgery, 2011, Volume: 54, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carotid Artery Diseases; Chi-Square Distribution; Clopidogrel; Drug Administration Schedule; Endarterectomy, Carotid; Female; Hospitals, University; Humans; Hypertension; Italy; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Registries; Reoperation; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2011
Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events. The American journal of cardiology, 2011, Nov-01, Volume: 108, Issue:9 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Aspirin; Cardiac Catheterization; Clopidogrel; Diabetes Mellitus; Female; Fibrinolytic Agents; Heart Failure; Hemorrhage; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Mechanical Thrombolysis; Middle Aged; Middle East; Myocardial Revascularization; Platelet Aggregation Inhibitors; Registries; Sex Distribution; Shock, Cardiogenic; Smoking; Stroke; Ticlopidine	2011
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. American heart journal, 2012, Volume: 164, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Fibrinolytic Agents; Heart Failure; Humans; Hypertension; Male; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome; Warfarin	2012
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the Journal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight; Cholesterol, LDL; Clopidogrel; Comorbidity; Cost of Illness; Depression; Diabetes Complications; Disease Management; Electrocardiography; Exercise; Exercise Test; Glycated Hemoglobin; Health Behavior; Humans; Hypertension; Life Style; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Physical Examination; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Quality of Life; Risk Assessment; Risk Factors; Risk Reduction Behavior; Smoking Cessation; Ticlopidine	2012
Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry. American heart journal, 2003, Volume: 145, Issue:2 Topics: Adenosine Diphosphate; Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Case-Control Studies; Clopidogrel; Coronary Disease; Female; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine	2003
I'm a 65-year-old man with high blood pressure and a family history of stroke. Which stroke-prevention medication would be better for me--aspirin or clopidogrel (Plavix)? Health news (Waltham, Mass.), 2003, Volume: 9, Issue:2 Topics: Aged; Aspirin; Clopidogrel; Family Health; Humans; Hypertension; Life Style; Male; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2003
Intracranial bleeding associated with clopidogrel. Cardiovascular drugs and therapy, 2005, Volume: 19, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Clopidogrel; Coronary Stenosis; Humans; Hypertension; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Tomography, X-Ray Computed	2005
[Prophylaxis of stroke]. Praxis, 2005, Jul-27, Volume: 94, Issue:30-31 Topics: Age Factors; Aged; Angioplasty, Balloon; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Brain Ischemia; Carotid Stenosis; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diet; Drug Therapy, Combination; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Life Style; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Sex Factors; Smoking Cessation; Stents; Stroke; Ticlopidine; Time Factors	2005
[Drugs induced Parkinsonism: the case of a 77 year old woman]. La Revue de medecine interne, 2006, Volume: 27, Issue:5 Topics: Acetaminophen; Adenocarcinoma; Aged; Antineoplastic Agents; Clopidogrel; Female; Humans; Hypertension; Parkinsonian Disorders; Ticlopidine	2006
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril. Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95, Issue:4 Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome	2006
Simultaneous, painless, homolateral oculomotor and trochlear nerve palsies in a patient with type 2 diabetes mellitus. Neuropathy or brainstem infarction? Acta diabetologica, 2006, Volume: 43, Issue:1 Topics: Aged; Cerebral Infarction; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Diagnosis, Differential; Female; Humans; Hyperlipidemias; Hypertension; Insulin; Magnetic Resonance Imaging; Paralysis; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2006
Nontraumatic spinal epidural hematoma associated with clopidogrel. Zentralblatt fur Neurochirurgie, 2006, Volume: 67, Issue:4 Topics: Aged; Back Pain; Clopidogrel; Female; Hematoma, Epidural, Spinal; Humans; Hypertension; Magnetic Resonance Imaging; Myocardial Infarction; Paraplegia; Platelet Aggregation Inhibitors; Spine; Stroke; Ticlopidine; Urinary Incontinence	2006
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:1 Topics: Actins; Adenosine Triphosphate; Angiotensin II; Animals; Arterioles; Blood Pressure; Cell Proliferation; Clopidogrel; Disease Models, Animal; Hypertension; Hypertrophy; Kidney; Male; Membrane Proteins; Mesangial Cells; Purinergic Antagonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Renin; Ticlopidine	2008
Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury. Journal of the American Society of Nephrology : JASN, 2008, Volume: 19, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Chronic Disease; Clopidogrel; Creatinine; Hypertension; Irbesartan; Kidney; Kidney Diseases; Nephrectomy; Platelet Aggregation Inhibitors; Rats; Tetrazoles; Ticlopidine; Wounds and Injuries	2008
Antithrombotic therapy in peripheral arterial disease. Cardiology clinics, 2008, Volume: 26, Issue:2 Topics: Anticoagulants; Aspirin; Atherosclerosis; Cilostazol; Clopidogrel; Comorbidity; Diabetic Angiopathies; Humans; Hypertension; Intermittent Claudication; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Tetrazoles; Thrombolytic Therapy; Ticlopidine	2008
Edge stenosis after intracoronary radiotherapy: angiographic, intravascular, and histological findings. Circulation, 2001, May-01, Volume: 103, Issue:17 Topics: Aged; Angioplasty, Balloon, Laser-Assisted; Anticoagulants; Aspirin; Brachytherapy; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Humans; Hyperlipidemias; Hypertension; Iridium Radioisotopes; Male; Myocardial Revascularization; Recurrence; Reoperation; Stents; Ticlopidine	2001